Page last updated: 2024-08-24

lathosterol and Fatty Liver, Nonalcoholic

lathosterol has been researched along with Fatty Liver, Nonalcoholic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bieghs, V; Buurman, WA; De Smet, E; Greve, JW; Guichot, YD; Hendrikx, T; Jeurissen, ML; Konings, M; Lütjohann, D; Mensink, RP; Plat, J; Rensen, SS; Shiri-Sverdlov, R; van Gorp, PJ; Vreugdenhil, AC; Walenbergh, SM1
Gylling, H; Hakkarainen, A; Hallikainen, M; Kotronen, A; Lundbom, N; Makkonen, J; Miettinen, TA; Sevastianova, K; Simonen, P; Yki-Järvinen, H1
Athias, A; Beacco, M; Bouillet, B; Brindisi, MC; Cercueil, JP; Duvillard, L; Guiu, B; Hillon, P; Petit, JM; Rollot, F; Verges, B1

Other Studies

3 other study(ies) available for lathosterol and Fatty Liver, Nonalcoholic

ArticleYear
Protective role of plant sterol and stanol esters in liver inflammation: insights from mice and humans.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Animals; Cholesterol; Desmosterol; Dietary Fats; Female; Humans; Inflammation; Liver; Macrophages; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Phytosterols

2014
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.
    Journal of hepatology, 2011, Volume: 54, Issue:1

    Topics: Adult; Aged; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Fatty Liver; Female; Humans; Insulin; Intestinal Absorption; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Sitosterols; Young Adult

2011
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes.
    Atherosclerosis, 2012, Volume: 224, Issue:2

    Topics: Aged; Biomarkers; Cholesterol; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Phytosterols; Risk Factors; Sitosterols; Treatment Outcome

2012